Olga I Isaeva
6PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 16, 2024
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.Iris Nederlof, Olga I Isaeva, Manon de Graaf
|Apr 10, 2023
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial.Leonie Voorwerk, Olga I Isaeva, Hugo M Horlings
|Oct 21, 2021
Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.Anastasia Gangaev, Elisa A Rozeman, Maartje W Rohaan
|Sep 28, 2021
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer.Dora Hammerl, John W M Martens, Mieke Timmermans
|May 11, 2021
Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features.Anastasia Gangaev, Steven L C Ketelaars, Olga I Isaeva
|Dec 16, 2020
Identification of differentially expressed gene modules in heterogeneous diseases.Olga Zolotareva, Sahand Khakabimamaghani, Olga I Isaeva
Pageof 1
Frequent Collaborators
4 joint publications
Ton N Schumacher
3 joint publications
Marleen Kok
3 joint publications
Hugo M Horlings
3 joint publications
Roberto Salgado
2 joint publications
Christian U Blank
2 joint publications
Hannah Garner
2 joint publications
Anastasia Gangaev
2 joint publications
Karin E de Visser
2 joint publications
Gabe S Sonke
2 joint publications
Iris Nederlof
